Stay up to date with the latest Symani news
Subscribe for timely email updates from MMI
"*" indicates required fields
Medical Microinstruments S.p.A. Announces €20M in Series A Funding to Advance Its Robotic Platform for Microsurgery
MMI SpA Launches Breakthrough Technology, Advancing Robotic Microsurgery with the World’s Smallest Wristed Surgical Instruments
Medical Microinstruments Appoints Healthcare Industry Veteran Mark Toland as Chief Executive Officer
Lymphovenous Anastomosis and Lymph Node Transfer Performed with Medical Microinstruments’ Symani® Surgical System at the Renowned University Hospital Zurich
Medical Microinstruments Participates in the “Minimally Invasive Robotic Surgery Systems (TREMIRS)” Project
The Symani Surgical System is a CE marked (CE 0051) medical device and is not approved or cleared by the FDA for commercial use in the U.S.
© 2023 Medical Microinstruments, Inc. All Rights Reserved.